275 related articles for article (PubMed ID: 12833153)
21. Activation of Escherichia coli UDP-3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase by Fe2+ yields a more efficient enzyme with altered ligand affinity.
Hernick M; Gattis SG; Penner-Hahn JE; Fierke CA
Biochemistry; 2010 Mar; 49(10):2246-55. PubMed ID: 20136146
[TBL] [Abstract][Full Text] [Related]
22. The nucleotide-binding site of Aquifex aeolicus LpxC.
Buetow L; Dawson A; Hunter WN
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1082-6. PubMed ID: 17077484
[TBL] [Abstract][Full Text] [Related]
23. Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis.
Barb AW; Zhou P
Curr Pharm Biotechnol; 2008 Feb; 9(1):9-15. PubMed ID: 18289052
[TBL] [Abstract][Full Text] [Related]
24. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme.
Jackman JE; Raetz CR; Fierke CA
Biochemistry; 1999 Feb; 38(6):1902-11. PubMed ID: 10026271
[TBL] [Abstract][Full Text] [Related]
25. Assignment of the 1H, 13C and 15N resonances of the LpxC deacetylase from Aquifex aeolicus in complex with the substrate-analog inhibitor TU-514.
Coggins BE; Li X; Hindsgaul O; Raetz CR; Zhou P
J Biomol NMR; 2004 Feb; 28(2):201-2. PubMed ID: 14755169
[No Abstract] [Full Text] [Related]
26. Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding.
Barb AW; Jiang L; Raetz CR; Zhou P
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18433-8. PubMed ID: 18025458
[TBL] [Abstract][Full Text] [Related]
27. A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466.
Cuny GD
Expert Opin Ther Pat; 2009 Jun; 19(6):893-9. PubMed ID: 19473108
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase.
Gennadios HA; Whittington DA; Li X; Fierke CA; Christianson DW
Biochemistry; 2006 Jul; 45(26):7940-8. PubMed ID: 16800620
[TBL] [Abstract][Full Text] [Related]
29. Uridine-based inhibitors as new leads for antibiotics targeting Escherichia coli LpxC.
Barb AW; Leavy TM; Robins LI; Guan Z; Six DA; Zhou P; Hangauer MJ; Bertozzi CR; Raetz CR
Biochemistry; 2009 Apr; 48(14):3068-77. PubMed ID: 19256534
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.
Mochalkin I; Knafels JD; Lightle S
Protein Sci; 2008 Mar; 17(3):450-7. PubMed ID: 18287278
[TBL] [Abstract][Full Text] [Related]
31. Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.
Warmus JS; Quinn CL; Taylor C; Murphy ST; Johnson TA; Limberakis C; Ortwine D; Bronstein J; Pagano P; Knafels JD; Lightle S; Mochalkin I; Brideau R; Podoll T
Bioorg Med Chem Lett; 2012 Apr; 22(7):2536-43. PubMed ID: 22401863
[TBL] [Abstract][Full Text] [Related]
32. EXAFS studies of the zinc sites of UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC).
McClure CP; Rusche KM; Peariso K; Jackman JE; Fierke CA; Penner-Hahn JE
J Inorg Biochem; 2003 Feb; 94(1-2):78-85. PubMed ID: 12620676
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial activities and characterization of novel inhibitors of LpxC.
Clements JM; Coignard F; Johnson I; Chandler S; Palan S; Waller A; Wijkmans J; Hunter MG
Antimicrob Agents Chemother; 2002 Jun; 46(6):1793-9. PubMed ID: 12019092
[TBL] [Abstract][Full Text] [Related]
34. N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay.
Furuya T; Shapiro AB; Comita-Prevoir J; Kuenstner EJ; Zhang J; Ribe SD; Chen A; Hines D; Moussa SH; Carter NM; Sylvester MA; Romero JAC; Vega CV; Sacco MD; Chen Y; O'Donnell JP; Durand-Reville TF; Miller AA; Tommasi RA
Bioorg Med Chem; 2020 Dec; 28(24):115826. PubMed ID: 33160146
[TBL] [Abstract][Full Text] [Related]
35. Active site metal ion in UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) switches between Fe(II) and Zn(II) depending on cellular conditions.
Gattis SG; Hernick M; Fierke CA
J Biol Chem; 2010 Oct; 285(44):33788-96. PubMed ID: 20709752
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups.
Pirrung MC; Tumey LN; Raetz CR; Jackman JE; Snehalatha K; McClerren AL; Fierke CA; Gantt SL; Rusche KM
J Med Chem; 2002 Sep; 45(19):4359-70. PubMed ID: 12213077
[TBL] [Abstract][Full Text] [Related]
37. Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway.
Hyland SA; Eveland SS; Anderson MS
J Bacteriol; 1997 Mar; 179(6):2029-37. PubMed ID: 9068651
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain.
Gao N; McLeod SM; Hajec L; Olivier NB; Lahiri SD; Bryan Prince D; Thresher J; Ross PL; Whiteaker JD; Doig P; Li AH; Hill PJ; Cornebise M; Reck F; Hale MR
Protein Expr Purif; 2014 Dec; 104():57-64. PubMed ID: 25240855
[TBL] [Abstract][Full Text] [Related]
39. The Complex Structure of Protein AaLpxC from
Fan S; Li D; Yan M; Feng X; Lv G; Wu G; Jin Y; Wang Y; Yang Z
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800069
[TBL] [Abstract][Full Text] [Related]
40. Binding of uridine 5'-diphosphate in the "basic patch" of the zinc deacetylase LpxC and implications for substrate binding.
Gennadios HA; Christianson DW
Biochemistry; 2006 Dec; 45(51):15216-23. PubMed ID: 17176043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]